X2VW0N7
Restriction Thoracic Aorta, Descending to New Technology Group 7 with Branched Synthetic Substitute with Intraluminal Device, Open Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | V Restriction |
| Body Part | W Thoracic Aorta, Descending |
| Approach | 0 Open |
| Device | N Branched Synthetic Substitute with Intraluminal Device |
| Qualifier | 7 New Technology Group 7 |
Operation Definition
Partially closing an orifice or the lumen of a tubular body part
Procedure Overview
This family covers procedures that narrow rather than close off a blood vessel or chamber, most notably placement of a coronary sinus reducer for patients with disabling angina that has not responded to medication, bypass surgery, or stenting, and whose coronary arteries are not amenable to further revascularization. The device is an hourglass-shaped implant delivered by catheter into the coronary sinus, the vein that drains blood from the heart muscle back to the right atrium. By creating a controlled narrowing at that point, it raises pressure in the small veins upstream, which appears to redistribute blood flow toward oxygen-starved areas of heart muscle and reduce chest pain episodes.
Patients considered for this therapy typically have exhausted standard options and continue to have frequent angina that limits daily activity. The procedure is done in a catheterization lab under fluoroscopic guidance, generally as an outpatient or short-stay procedure, and does not involve opening the chest.
Anatomy & Axis Detail
Thoracic Aorta, Descending
The descending thoracic aorta runs from the aortic isthmus, just past the left subclavian artery, down to the diaphragm, and it is a common site for degenerative aneurysms, traumatic tears, and Type B dissections. Restriction of this segment with new-technology devices generally refers to endovascular placement of a stent-graft or similar system that narrows the true lumen to promote false lumen thrombosis in dissection or to reduce flow into a weakened aortic wall. The segment's course through the posterior mediastinum, close to the intercostal arteries supplying the spinal cord, makes the extent of coverage clinically significant, since excessive restriction along its length can compromise spinal perfusion. Documentation should clarify that the device is confined to the descending thoracic portion, distinguishing it from procedures extending into the arch or the abdominal aorta.
Approach: Open
Open approach in New Technology denotes access to the target site through a surgical incision that exposes the body part directly to view and instrumentation. It stands apart from percutaneous and endoscopic approaches, which achieve access through small punctures or existing openings rather than a deliberate surgical opening of tissue.
Device / Substance / Technology: Branched Synthetic Substitute with Intraluminal Device
This value identifies a synthetic vascular graft that includes branches along with an intraluminal device component, typically used in complex aortic repairs requiring both a branched conduit and an internally placed reinforcing element. It differs from a plain branched synthetic substitute by the added intraluminal device, and from simple intraluminal devices by incorporating the branched synthetic graft structure. The combination supports repair of aneurysms involving multiple branch vessels.
Qualifier: New Technology Group 7
As a qualifier value, Group 7 marks a code as belonging to the set of new technologies approved for use in the 2020-2021 fiscal year, a period that included a notable expansion of infectious-disease-related add-on codes. The label does not describe what the technology does; that detail sits in the table and other axis values. It is distinguished from adjoining groups solely by its approval-year cohort.
Coding & Documentation
Assignment depends on documentation identifying the coronary sinus as the treated body part and confirming that a new-technology intraluminal device was deployed, since this root operation and device combination is what distinguishes the procedure from a standard coronary intervention. The operative note should specify catheter-based delivery and device sizing/deployment, along with confirmation of correct final position by contrast venography. A common assignment error is defaulting to a generic Dilation or Occlusion code for coronary sinus work, when the reducer's mechanism is a partial, fixed narrowing rather than either widening a vessel or completely blocking it. Coders should also verify the approach value reflects percutaneous access and confirm the device is captured under the correct new-technology group rather than a conventional device value.